Navigator Medicines
Scotch Plains, US · Founded 2024 · Delaware corporation · 2 known investors
Founders & leadership
NM
NAVEEN MANU DARYANIExecutive
SB
STEPHEN BASIL THOMASNamed on SEC filing
WD
WILLIAM DALEY BONIFICIONamed on SEC filing
Board
AL

WJ

Investors · 2
Reported raises · per SEC filings
Form D private placements$50M disclosed across 1 round · 2024
▶$50MraisedSep 2024 · 4 investors · BiotechnologyRule 506(b)
▶$50MraisedSep 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- NAVEEN MANU DARYANIExecutive Officer
- ANDREW LEVINDirector
- STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
- WILLIAM DALEY BONIFICIOExecutive Officer, Promoter
- WOUTER JOUSTRADirector
- Offering amount
- $100M
- Amount sold
- $50M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Navigator Medicines's investors?
- Navigator Medicines's investors include RA Capital, Forbion.
- How much funding has Navigator Medicines raised?
- Navigator Medicines has disclosed $50M raised across 1 round.
- Where is Navigator Medicines headquartered?
- Navigator Medicines is headquartered in Scotch Plains, US.